ArticleFrontiers in immunology2026
CyTOF profiling identifies location-specific peripheral immune checkpoint and immune cell subset in mild ischemic stroke.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatiotemporally precise immune reprogramming: a new paradigm for next-generation neuroimmune therapy in ischemic stroke.Frontiers in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mild ischemic stroke accounts for over half of all stroke cases, yet how peripheral immune responses evolve over time-and how they differ by infarct location-remains poorly defined. Methods: Peripheral blood was collected from ten patients with mild ischemic stroke and five matched controls at days 1, 3, and 7 after onset. Patients were stratified by cortical or subcortical infarction. High-dimensional mass cytometry was used to characterize immune cell composition and immune checkpoint expression. Results: Subcortical infarction was associated with sustained expansion of classical monocytes, persistent reduction of intermediate monocytes, and delayed PD-1/PD-L1 regulatory signaling, indicating prolonged myeloid-driven inflammation. In contrast, cortical infarction exhibited a more balanced monocyte profile and earlier PD-1 upregulation on dendritic cells and classical monocytes. CD4⁺ and CD8⁺ T-cell subsets showed distinct, location-dependent dynamics: cortical infarction induced earlier modulation of memory and regulatory phenotypes, whereas subcortical infarction produced slower but more persistent shifts. CCR5-defined CD8⁺ T-cell subsets also differed markedly, with subcortical infarction showing enrichment of CCR5⁺ effector cells, reduced checkpoint expression, and contraction of the CCR5⁻ compartment. Discussion: Peripheral immune remodeling in mild ischemic stroke displays clear infarct location-specific trajectories. These findings highlight infarct topology as a critical determinant of post-stroke immune regulation and support the development of location-adapted immunomodulatory strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.